Common risk factors of breast and ovarian cancer: recent view

2004 ◽  
Vol 14 (5) ◽  
pp. 721-740 ◽  
Author(s):  
G. C. Zografos ◽  
M. Panou ◽  
N. Panou
2004 ◽  
Vol 14 (5) ◽  
pp. 721-740 ◽  
Author(s):  
G. C. Zografos ◽  
M. Panou ◽  
N. Panou

Clinicians, epidemiologists, and public health specialists tend to examine breast and ovarian cancer separately. Although this seems fairly rational and expected, both malignancies are estrogen related and thus share many risk factors. In this review, we investigate the common familial, reproductive, anthropometric, nutritional, and lifestyle risk factors of breast and ovarian cancer. We believe that the parallel examination of the two cancer types could significantly contribute to an improved prevention of “gynecological cancer” as a whole.


2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e12017-e12017 ◽  
Author(s):  
M. C. Katapodi ◽  
S. L. DeFlon ◽  
K. J. Milliron ◽  
L. L. Northouse ◽  
S. Merajver

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Elisabeth Jarhelle ◽  
Hilde Monica Frostad Riise Stensland ◽  
Geir Åsmund Myge Hansen ◽  
Siri Skarsfjord ◽  
Christoffer Jonsrud ◽  
...  

AbstractFamilies with breast and ovarian cancer are often tested for disease associated sequence variants in BRCA1 and BRCA2. Pathogenic sequence variants (PVs) in these two genes are known to increase breast and ovarian cancer risks in females. However, in most families no PVs are detected in these two genes. Currently, several studies have identified other genes involved in hereditary breast and ovarian cancer (HBOC). To identify genetic risk factors for breast and ovarian cancer in a Norwegian HBOC cohort, 101 breast and/or ovarian cancer patients negative for PVs and variants of unknown clinical significance (VUS) in BRCA1/2 were screened for PVs in 94 genes using next-generation sequencing. Sixteen genes were closely scrutinized. Nine different deleterious germline PVs/likely pathogenic variants (LPVs) were identified in seven genes in 12 patients: three in ATM, and one in CHEK2, ERCC5, FANCM, RAD51C, TP53 and WRN. Additionally, 32 different VUSs were identified and these require further characterization. For carriers of PV/LPV in many of these genes, there are no national clinical management programs in Norway. The diversity of genetic risk factors possibly involved in cancer development show the necessity for more knowledge to improve the clinical follow-up of this genetically diverse patient group.


2021 ◽  
Vol 12 (02) ◽  
pp. 245-250
Author(s):  
Alexander L. Kostrinsky-Thomas ◽  
Fuki M. Hisama ◽  
Thomas H. Payne

Abstract Background Clinicians express concern that they may be unaware of important information contained in voluminous scanned and other outside documents contained in electronic health records (EHRs). An example is “unrecognized EHR risk factor information,” defined as risk factors for heritable cancer that exist within a patient's EHR but are not known by current treating providers. In a related study using manual EHR chart review, we found that half of the women whose EHR contained risk factor information meet criteria for further genetic risk evaluation for heritable forms of breast and ovarian cancer. They were not referred for genetic counseling. Objectives The purpose of this study was to compare the use of automated methods (optical character recognition with natural language processing) versus human review in their ability to identify risk factors for heritable breast and ovarian cancer within EHR scanned documents. Methods We evaluated the accuracy of the chart review by comparing our criterion standard (physician chart review) versus an automated method involving Amazon's Textract service (Amazon.com, Seattle, Washington, United States), a clinical language annotation modeling and processing toolkit (CLAMP) (Center for Computational Biomedicine at The University of Texas Health Science, Houston, Texas, United States), and a custom-written Java application. Results We found that automated methods identified most cancer risk factor information that would otherwise require clinician manual review and therefore is at risk of being missed. Conclusion The use of automated methods for identification of heritable risk factors within EHRs may provide an accurate yet rapid review of patients' past medical histories. These methods could be further strengthened via improved analysis of handwritten notes, tables, and colloquial phrases.


Sign in / Sign up

Export Citation Format

Share Document